Can you provide the average price target for BP PLC-SPONS ADR stock?
33 analysts have analysed BP and the average price target is 46.21 USD. This implies a price decrease of -2.98% is expected in the next year compared to the current price of 47.63.
NYSE:BP • US0556221044
View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for BP PLC-SPONS ADR (BP).
| Date | Firm | Action | From → To |
|---|---|---|---|
| 2026-04-15 | UBS | Upgrade | Neutral -> Buy |
| 2026-04-09 | Wells Fargo | Maintains | Equal-Weight -> Equal-Weight |
| 2026-03-20 | HSBC | Upgrade | Reduce -> Hold |
| 2026-03-12 | Piper Sandler | Maintains | Neutral -> Neutral |
| 2026-02-11 | Piper Sandler | Maintains | Neutral -> Neutral |
| 2026-01-08 | Piper Sandler | Maintains | Neutral -> Neutral |
| 2026-01-06 | Evercore ISI Group | Downgrade | Outperform -> In-Line |
| 2025-11-10 | Piper Sandler | Maintains | Neutral -> Neutral |
| 2025-11-05 | Wells Fargo | Maintains | Equal-Weight -> Equal-Weight |
| 2025-10-17 | Wells Fargo | Initiate | Equal-Weight |
| 2025-10-17 | Raymond James | Maintains | Outperform -> Outperform |
| 2025-10-09 | ScotiaBank | Maintains | Sector Outperform -> Sector Outperform |
| 2025-09-25 | Raymond James | Maintains | Outperform -> Outperform |
| 2025-09-15 | Exane BNP Paribas | Upgrade | Neutral -> Outperform |
| 2025-08-20 | Melius Research | Initiate | Buy |
| 2025-08-18 | Piper Sandler | Maintains | Neutral -> Neutral |
| 2025-08-14 | ScotiaBank | Upgrade | Sector Perform -> Sector Outperform |
| 2025-07-15 | Piper Sandler | Maintains | Neutral -> Neutral |
| 2025-07-11 | ScotiaBank | Maintains | Sector Perform -> Sector Perform |
| 2025-06-26 | Wells Fargo | Maintains | Equal-Weight -> Equal-Weight |
| 2025-05-19 | Jefferies | Downgrade | Buy -> Hold |
| 2025-05-13 | Piper Sandler | Maintains | Neutral -> Neutral |
| 2025-04-11 | ScotiaBank | Maintains | Sector Perform -> Sector Perform |
| 2025-03-19 | TD Securities | Downgrade | Buy -> Hold |
| 2025-02-20 | JP Morgan | Upgrade | Underweight -> Neutral |
| 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 210.13B -12.95% | 189.185B -9.97% | 189.335B 0.08% | 208B 9.86% | 197.276B -5.16% | 193.486B -1.92% | 213.054B 10.11% | 217.314B 2.00% | N/A | N/A | |
| EBITDA YoY % growth | 46.288B -16.54% | 29.521B -36.22% | 33.661B 14.02% | 40.652B 20.77% | 38.387B -5.57% | 37.422B -2.51% | 37.114B -0.82% | 39.913B 7.54% | N/A | N/A | |
| EBIT YoY % growth | 30.36B -26.21% | 12.899B -57.51% | 15.496B 20.13% | 20.119B 29.83% | 18.893B -6.09% | 19.834B 4.98% | 19.946B 0.56% | 20.17B 1.12% | 27.874B 38.20% | 28.501B 2.25% | |
| Operating Margin | 14.45% | 6.82% | 8.18% | 9.67% | 9.58% | 10.25% | 9.36% | 9.28% | N/A | N/A | |
| EPS YoY % growth | 4.73 -45.14% | 3.23 -31.77% | 2.82 -12.43% | 3.71 31.42% | 3.71 0.05% | 3.75 0.88% | 3.80 1.46% | 4.08 7.31% | N/A | N/A |
All data in USD
| Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | Q1 / 27 | Q2 / 27 | Q3 / 27 | Q4 / 27 | Q1 / 28 | Q2 / 28 | Q3 / 28 | Q4 / 28 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| EPS Q2Q % growth | 0.96 100.18% | 1.45 62.00% | 1.19 39.65% | 0.96 60.24% | 0.88 -7.96% | 0.92 -36.62% | 0.94 -20.53% | 0.97 1.21% | 0.81 -7.81% | 0.88 -4.21% | 0.89 -5.66% | 0.86 -11.86% |
| Revenue Q2Q % growth | 53.647B 12.04% | 66.24B 38.93% | 58.041B 17.85% | 53.453B 11.96% | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| EBITDA Q2Q % growth | 10.585B 29.53% | 13.95B 6.24% | 12.695B -29.45% | 11.268B -46.78% | 9.722B -8.15% | 9.813B -29.66% | 9.848B -22.43% | 9.521B -15.50% | 9.484B -2.45% | 9.72B -0.95% | 9.787B -0.62% | 9.498B -0.24% |
| EBIT Q2Q % growth | 6.173B 56.83% | 7.813B 87.27% | 6.706B 53.11% | 5.675B 88.66% | 6.763B 9.56% | 6.6B -15.53% | 6.625B -1.21% | 6.552B 15.45% | 5.849B -13.51% | 5.895B -10.68% | 5.862B -11.52% | 5.791B -11.61% |
All data in USD
33 analysts have analysed BP and the average price target is 46.21 USD. This implies a price decrease of -2.98% is expected in the next year compared to the current price of 47.63.
BP PLC-SPONS ADR (BP) will report earnings on 2026-04-28, before the market open.
The consensus EPS estimate for the next earnings of BP PLC-SPONS ADR (BP) is 0.96 USD and the consensus revenue estimate is 53.65B USD.
The number of analysts covering BP PLC-SPONS ADR (BP) is 33.